MGM Stock Surges as Macau, Digital Businesses Thrive
Key Points
- The S&P 500 rose 1.0% on Thursday, February 13, as executive orders delayed the possible implementation of mutual tariffs.
- The strength for China and digital businesses provided MGM Resorts a strong quarter, with casino operators surging stocks.
- West Pharmaceutical Services shares fell after drug packaging providers issued guidance that exceeded expectations.
Major U.S. stock indexes rose when President Donald Trump signed an executive order directing his administration to sign with his administration Investigate mutual tariffs But stop collecting taxes immediately.
Thursday’s market action also coincides with the release of the latest Manufacturer Price Index (PPI) data, which shows Wholesale inflation rises In January, similar signs were responded to the previous day’s Consumer Price Index (CPI) report.
S&P 500 S&P 500 closed 1.0% of the meetings. Dow Jones Industrial Industrial increased by 0.8%, while strength in the technology sector helped boost the Nasdaq by 1.5%.
MGM Resorts (MGM) Shares soared 17.5%, garnering the largest 500 shares after casino and hotel operators rose above sales and profit estimates in the fourth quarter of 2024. Additional enhancements are provided. After the report, CFRA analysts upgraded MGM stock to a “buy” citing more optimistic financial forecasts and the company’s aggressive stock buyback program.
Shares of Molson Coors (Tap) soared 9.5% after the alcoholic beverage giant’s quarterly conf regret. Despite the decline in revenue throughout the year, the brewers outperformed sales and profit forecasts and pointed to their success in holding recent market share growth and favorable sales portfolio and prices.
GE Healthcare Technologies (pig) is a medical product and service provider developed from GE in 2023, with better-than-expected profits in the fourth quarter, with its stock rising 8.8% on Thursday. Despite some weaknesses in China, the company benefits from the strength of the United States, and the strong demand for advanced visualization solutions is that the drug diagnosis business contributes to revenue growth.
Western Pharmaceutical Services (WST) The stock’s losses were heavyweight than any other S&P 500 on Thursday, down 38.2%. While manufacturers of injectable drug delivery devices and other drug packaging products were estimated at a fourth-quarter profit of higher than their 2025 guidance, it was well below consensus forecasts. The company said dollar strength, customer inventory clearing and large capital expenditures could impact future revenues.
An incredible look also obscures the powerful earnings report of Zebra technology (ZBRA), production of barcode scanners and other inventory management systems. Although sales and profits exceeded estimates in the fourth quarter, full-year revenue guidance was not forecast, reflecting the impact of a strong dollar and the uncertainty related to tariffs and global trade. Zebra Technologies shares fell 8.4%.
Shares of Iron Mountain, a corporate information management providerIRM) Sinks 7.3%. Despite the company’s strong performance in its data center business and its storage and services sectors, revenue in the fourth quarter was underestimated, while increased interest expenses put pressure on the results.